30.70
price down icon0.39%   -0.12
after-market 시간 외 거래: 30.67 -0.03 -0.10%
loading
전일 마감가:
$30.82
열려 있는:
$30.7
하루 거래량:
2.02M
Relative Volume:
1.02
시가총액:
$5.07B
수익:
$1.51B
순이익/손실:
$333.35M
주가수익비율:
15.74
EPS:
1.95
순현금흐름:
$315.22M
1주 성능:
+3.02%
1개월 성능:
+2.33%
6개월 성능:
+6.71%
1년 성능:
+19.46%
1일 변동 폭
Value
$30.35
$31.00
1주일 범위
Value
$28.41
$32.13
52주 변동 폭
Value
$25.16
$36.45

Alkermes Plc Stock (ALKS) Company Profile

Name
명칭
Alkermes Plc
Name
전화
00-353-1-772-8000
Name
주소
CONNAUGHT HOUSE, DUBLIN 4
Name
직원
1,800
Name
트위터
@alkermes
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
ALKS's Discussions on Twitter

ALKS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ALKS
Alkermes Plc
30.70 5.09B 1.51B 333.35M 315.22M 1.95
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Alkermes Plc Stock (ALKS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-26 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2025-09-03 개시 Wells Fargo Overweight
2025-07-15 개시 Goldman Buy
2025-06-17 업그레이드 UBS Neutral → Buy
2025-05-28 개시 Needham Buy
2025-03-13 개시 RBC Capital Mkts Sector Perform
2025-03-04 업그레이드 UBS Sell → Neutral
2025-02-11 개시 Deutsche Bank Buy
2024-11-05 업그레이드 Stifel Hold → Buy
2024-06-17 개시 TD Cowen Buy
2024-03-19 개시 Robert W. Baird Outperform
2024-02-20 다운그레이드 UBS Neutral → Sell
2023-11-20 재개 JP Morgan Neutral
2023-10-24 업그레이드 Evercore ISI In-line → Outperform
2023-10-17 개시 UBS Neutral
2022-11-03 업그레이드 Piper Sandler Neutral → Overweight
2022-10-14 업그레이드 BofA Securities Underperform → Neutral
2022-08-16 개시 Piper Sandler Neutral
2022-04-22 재개 Goldman Buy
2022-04-20 개시 Goldman Buy
2022-01-27 업그레이드 Cantor Fitzgerald Hold → Overweight
2021-12-01 개시 Citigroup Neutral
2021-10-07 업그레이드 Jefferies Hold → Buy
2021-09-02 다운그레이드 BofA Securities Neutral → Underperform
2020-10-15 업그레이드 Mizuho Neutral → Buy
2020-07-30 다운그레이드 Goldman Neutral → Sell
2020-02-14 다운그레이드 BofA/Merrill Buy → Neutral
2020-02-14 재확인 H.C. Wainwright Neutral
2020-02-14 다운그레이드 JP Morgan Overweight → Neutral
2020-02-06 개시 Mizuho Neutral
2020-01-31 업그레이드 Wolfe Research Underperform → Peer Perform
2019-09-05 업그레이드 Morgan Stanley Underweight → Equal-Weight
2019-07-15 업그레이드 Goldman Sell → Neutral
2019-05-31 개시 H.C. Wainwright Neutral
2019-05-01 다운그레이드 Citigroup Buy → Neutral
2018-12-19 다운그레이드 Goldman Neutral → Sell
2018-12-14 개시 Wolfe Research Underperform
2018-12-13 다운그레이드 Credit Suisse Outperform → Underperform
2018-11-05 개시 Piper Jaffray Neutral
2018-08-07 개시 Stifel Hold
2018-06-21 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2018-06-06 개시 B. Riley FBR, Inc. Buy
2018-05-16 업그레이드 Citigroup Neutral → Buy
2018-05-11 개시 BofA/Merrill Buy
모두보기

Alkermes Plc 주식(ALKS)의 최신 뉴스

pulisher
06:20 AM

Why Alkermes plc stock appeals to analystsBuy Signal & Safe Capital Investment Plans - newser.com

06:20 AM
pulisher
06:17 AM

Alkermes plc Just Recorded A 62% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st

06:17 AM
pulisher
06:02 AM

Can Alkermes plc stock deliver consistent earnings growthMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com

06:02 AM
pulisher
04:50 AM

Exit strategy if you’re trapped in Alkermes plc2025 Price Momentum & Smart Investment Allocation Tips - newser.com

04:50 AM
pulisher
03:33 AM

Price momentum metrics for Alkermes plc explainedDay Trade & Technical Pattern Based Signals - newser.com

03:33 AM
pulisher
02:56 AM

What moving averages say about Alkermes plcJuly 2025 Trade Ideas & Daily Market Momentum Tracking - newser.com

02:56 AM
pulisher
02:44 AM

Real time social sentiment graph for Alkermes plcBuy Signal & Free Accurate Trade Setup Notifications - newser.com

02:44 AM
pulisher
01:51 AM

What to do if you’re stuck in Alkermes plcQuarterly Trade Summary & Risk Managed Investment Signals - newser.com

01:51 AM
pulisher
12:56 PM

How resilient is Alkermes plc stock in market downturnsTrade Volume Report & Fast Momentum Stock Entry Tips - newser.com

12:56 PM
pulisher
12:26 PM

Is Alkermes plc (8AK) stock a safe buy pre earnings2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com

12:26 PM
pulisher
12:07 PM

What recovery options are there for Alkermes plcQuarterly Investment Review & Community Trade Idea Sharing - newser.com

12:07 PM
pulisher
Oct 30, 2025

Is Alkermes plc forming a bottoming baseWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Alkermes Q3 2025 Earnings: Strong Growth & Strategic Moves - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Alkermes PLC (ALKS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion - Investing.com Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Alkermes (NASDAQ:ALKS) Price Target Cut to $42.00 by Analysts at Wells Fargo & Company - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Alkermes (NASDAQ:ALKS) Price Target Raised to $44.00 - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Alkermes Plc Experiences Evaluation Revision Amid Mixed Technical Indicators and Performance Trends - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Why Alkermes plc stock is seen as undervalued2025 Big Picture & AI Forecasted Stock Moves - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Order flow analysis tools used on Alkermes plc2025 Performance Recap & Entry Point Strategy Guides - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What technical patterns form on Alkermes plc (8AK) stock chartsAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Applying Wyckoff theory to Alkermes plc stockEarnings Summary Report & Real-Time Buy Signal Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Alkermes Q3 Earnings and Revenues Beat Estimates, 2025 View Raised - The Globe and Mail

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes (ALKS) Maintains Overweight Rating as Wells Fargo Lowers Price Target | ALKS Stock News - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Deutsche Bank Adjusts Alkermes Price Target to $55 From $53, Maintains Buy Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes (NASDAQ:ALKS) Announces Quarterly Earnings Results - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes (NASDAQ:ALKS) Releases FY 2025 Earnings Guidance - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes plc (NASDAQ:ALKS) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 29, 2025
pulisher
Oct 29, 2025

Needham Maintains Buy Rating for ALKS, Raises Price Target | ALKS Stock News - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

Y Intercept Hong Kong Ltd Increases Stock Position in Alkermes plc $ALKS - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes plc $ALKS Shares Sold by Allianz Asset Management GmbH - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes’ Acquisition of Avadel Faces Uncertainty Amid Regulatory and Financial Hurdles - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Alkermes plc Reports Strong Q3 2025 Results - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Decoding Alkermes PLC (ALKS): A Strategic SWOT Insight - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Relative strength of Alkermes plc in sector analysisQuarterly Earnings Summary & Weekly Momentum Stock Picks - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Alkermes: Q3 Earnings Snapshot - Stamford Advocate

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes Plc earnings beat by $0.11, revenue topped estimates - Investing.com Australia

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes Q3 2025 Earnings Call Transcript - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings call transcript: Alkermes beats Q3 2025 expectations, shares rise By Investing.com - Investing.com Nigeria

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes (ALKS) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes Lifts Outlook After Beating Revenue Targets - Finimize

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes plc. SEC 10-Q Report - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings call transcript: Alkermes beats Q3 2025 expectations, shares rise - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes (ALKS) Surpasses Revenue Expectations in Q3, Sets Sights on Future Growth - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes shares rise 5% as third quarter results top expectations By Investing.com - Investing.com Australia

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings Flash (ALKS) Alkermes plc Reports Q3 Revenue $394.2M, vs. FactSet Est of $356.9M - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Alkermes PLC Q3 2025 Earnings: EPS of $0.49 and Revenue of $394. - GuruFocus

Oct 28, 2025

Alkermes Plc (ALKS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Alkermes Plc 주식 (ALKS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Oct 15 '25
Sale
31.53
9,000
283,776
73,740
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
자본화:     |  볼륨(24시간):